{"id":"https://openalex.org/W2400758641","doi":null,"title":"[99mTc/90Y]-1,4,7,10 Tetraazacyclododecane-N,N\u2019,N\u2019\u2019,N\u2019\u2019\u2019-tetraacetic acid phenylalanine derivative conjugated to anti-epidermal growth factor receptor antibody ior egf/r3","display_name":"[99mTc/90Y]-1,4,7,10 Tetraazacyclododecane-N,N\u2019,N\u2019\u2019,N\u2019\u2019\u2019-tetraacetic acid phenylalanine derivative conjugated to anti-epidermal growth factor receptor antibody ior egf/r3","publication_year":2009,"publication_date":"2009-10-15","ids":{"openalex":"https://openalex.org/W2400758641","mag":"2400758641"},"language":"en","primary_location":{"id":"mag:2400758641","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/20641461","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051940203","display_name":"Puja Panwar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114989","display_name":"Institute of Nuclear Medicine & Allied Sciences","ror":"https://ror.org/029g42942","country_code":"IN","type":"facility","lineage":["https://openalex.org/I1340206300","https://openalex.org/I2799351866","https://openalex.org/I4210114989","https://openalex.org/I4210150591"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Puja Panwar","raw_affiliation_strings":["Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India","institution_ids":["https://openalex.org/I4210114989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033362815","display_name":"Normando Iznaga-Escobar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2355400","display_name":"Center of Molecular Immunology (Cuba)","ror":"https://ror.org/01gh7yb82","country_code":"CU","type":"company","lineage":["https://openalex.org/I2355400"]}],"countries":["CU"],"is_corresponding":false,"raw_author_name":"Normando Iznaga-Escobar","raw_affiliation_strings":["Center for Molecular Immunology, PO box 16040, Havana 11600, Cuba"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Molecular Immunology, PO box 16040, Havana 11600, Cuba","institution_ids":["https://openalex.org/I2355400"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104561476","display_name":"Pushpa Mishra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114989","display_name":"Institute of Nuclear Medicine & Allied Sciences","ror":"https://ror.org/029g42942","country_code":"IN","type":"facility","lineage":["https://openalex.org/I1340206300","https://openalex.org/I2799351866","https://openalex.org/I4210114989","https://openalex.org/I4210150591"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Pushpa Mishra","raw_affiliation_strings":["Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India","institution_ids":["https://openalex.org/I4210114989"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Vibha Srivastava","orcid":"https://orcid.org/0000-0002-3031-6984","observed_orcids":["https://orcid.org/0000-0002-3031-6984"]},"institutions":[{"id":"https://openalex.org/I110166357","display_name":"University of Delhi","ror":"https://ror.org/04gzb2213","country_code":"IN","type":"education","lineage":["https://openalex.org/I110166357"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Vibha Srivastava","raw_affiliation_strings":["Dr. B.R. Ambedkar Center for Biomedical Research,University of Delhi , Delhi , 110007 , India"],"raw_orcid":"https://orcid.org/0000-0002-3031-6984","affiliations":[{"raw_affiliation_string":"Dr. B.R. Ambedkar Center for Biomedical Research,University of Delhi , Delhi , 110007 , India","institution_ids":["https://openalex.org/I110166357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100700219","display_name":"Rakesh Kumar Sharma","orcid":"https://orcid.org/0000-0003-0131-2228","observed_orcids":["https://orcid.org/0000-0003-0131-2228"]},"institutions":[{"id":"https://openalex.org/I4210114989","display_name":"Institute of Nuclear Medicine & Allied Sciences","ror":"https://ror.org/029g42942","country_code":"IN","type":"facility","lineage":["https://openalex.org/I1340206300","https://openalex.org/I2799351866","https://openalex.org/I4210114989","https://openalex.org/I4210150591"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Rakesh Kumar Sharma","raw_affiliation_strings":["Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India"],"raw_orcid":"https://orcid.org/0000-0003-0131-2228","affiliations":[{"raw_affiliation_string":"Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India","institution_ids":["https://openalex.org/I4210114989"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054927028","display_name":"Ramesh Chandra","orcid":"https://orcid.org/0000-0002-7150-3604","observed_orcids":["https://orcid.org/0000-0002-7150-3604"]},"institutions":[{"id":"https://openalex.org/I110166357","display_name":"University of Delhi","ror":"https://ror.org/04gzb2213","country_code":"IN","type":"education","lineage":["https://openalex.org/I110166357"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Ramesh Chandra","raw_affiliation_strings":["Dr. B.R. Ambedkar Center for Biomedical Research,University of Delhi , Delhi , 110007 , India"],"raw_orcid":"https://orcid.org/0000-0002-7150-3604","affiliations":[{"raw_affiliation_string":"Dr. B.R. Ambedkar Center for Biomedical Research,University of Delhi , Delhi , 110007 , India","institution_ids":["https://openalex.org/I110166357"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022699290","display_name":"Anil Kumar Mishra","orcid":"https://orcid.org/0000-0003-2523-9045","observed_orcids":["https://orcid.org/0000-0003-2523-9045","https://orcid.org/0000-0002-7451-4683","https://orcid.org/0000-0002-7467-9146"]},"institutions":[{"id":"https://openalex.org/I4210114989","display_name":"Institute of Nuclear Medicine & Allied Sciences","ror":"https://ror.org/029g42942","country_code":"IN","type":"facility","lineage":["https://openalex.org/I1340206300","https://openalex.org/I2799351866","https://openalex.org/I4210114989","https://openalex.org/I4210150591"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Anil K. Mishra","raw_affiliation_strings":["Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India"],"raw_orcid":"https://orcid.org/0000-0003-2523-9045","affiliations":[{"raw_affiliation_string":"Division of Cyclotron and Radiopharmaceutical Sciences, Institute of Nuclear Medicine and allied Sciences, Delhi 110054, India","institution_ids":["https://openalex.org/I4210114989"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077155083","display_name":"Arvind Chopra","orcid":"https://orcid.org/0000-0002-4347-9651","observed_orcids":["https://orcid.org/0000-0002-4347-9651"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210109390","display_name":"National Center for Biotechnology Information","ror":"https://ror.org/02meqm098","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I2800548410","https://openalex.org/I4210109390"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arvind Chopra","raw_affiliation_strings":["National Center for Biotechnology Information, NLM, NIH, Bethesda, MD 20894"],"raw_orcid":"https://orcid.org/0000-0002-4347-9651","affiliations":[{"raw_affiliation_string":"National Center for Biotechnology Information, NLM, NIH, Bethesda, MD 20894","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210109390"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/humanized-antibody","display_name":"humanized monoclonal antibody","score":0.8539999723434448},{"id":"https://openalex.org/keywords/radiolabeled-antibodies","display_name":"radiolabeled antibodies","score":0.5860000252723694},{"id":"https://openalex.org/keywords/tyrosine-kinase-inhibitors","display_name":"tyrosine kinase inhibitors","score":0.5860000252723694},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.6240000128746033},{"id":"https://openalex.org/keywords/tumor-imaging","display_name":"tumor imaging","score":0.5410000085830688},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.43700000643730164},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.3529999852180481},{"id":"https://openalex.org/keywords/liver-accumulation","display_name":"liver accumulation","score":0.4390000104904175},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.44600000977516174},{"id":"https://openalex.org/keywords/tumor-growth-inhibition","display_name":"tumor growth inhibition","score":0.3869999945163727},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.32100000977516174},{"id":"https://openalex.org/keywords/tumor-necrosis","display_name":"tumor necrosis","score":0.3089999854564667}],"concepts":[{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.9188046455383301},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.8142883777618408},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7252581119537354},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6074452996253967},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.6026125550270081},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5426356196403503},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.45630520582199097},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.44449129700660706},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.44145360589027405},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.37332701683044434},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.32953792810440063},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.300653338432312},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2837405204772949}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2400758641","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/20641461","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1974842735","https://openalex.org/W1992913621","https://openalex.org/W2008249862","https://openalex.org/W2018448220","https://openalex.org/W2028015151","https://openalex.org/W2107881697","https://openalex.org/W2156710240","https://openalex.org/W2468182085"],"related_works":["https://openalex.org/W2406194503","https://openalex.org/W2439687074","https://openalex.org/W2430770330","https://openalex.org/W2182489229","https://openalex.org/W7208196032","https://openalex.org/W2173906117","https://openalex.org/W2401722093","https://openalex.org/W2416291114","https://openalex.org/W199132814","https://openalex.org/W2071803372"],"abstract_inverted_index":{"The":[0],"epidermal":[1],"growth":[2],"factor":[3],"receptor":[4,10,41],"(EGFR)":[5],"is":[6,29,42,246],"a":[7,57,136,161,182,239,289,298,317],"cell":[8,362],"surface":[9],"that":[11,191,208,277],"interacts":[12],"with":[13,75,253,316,325,351],"several":[14,92],"different":[15,168],"ligands":[16],"(1),":[17],"mediates":[18],"its":[19,52],"activity":[20],"through":[21],"an":[22,152,223,227],"intracellular":[23],"tyrosine":[24],"kinase":[25],"(TK)":[26],"(2),":[27],"and":[28,36,51,68,95,111,123,155,175,204,234,255,259,305],"involved":[30],"in":[31,46,54,100,181,219,261,271,292,348,358],"the":[32,47,61,65,69,87,119,127,149,158,176,205,212,232,268,274,293,303,312,342],"survival,":[33],"growth,":[34],"proliferation,":[35],"differentiation":[37],"of":[38,49,89,129,135,151,160,211,236,267,273,281,308,320,341],"cells.":[39],"This":[40],"known":[43,247],"to":[44,156,167,225,301],"participate":[45],"metastases":[48],"cancers,":[50],"overexpression":[53],"tumors":[55,131,190,356,369],"indicates":[56],"poor":[58],"outcome":[59],"for":[60,86,126,148,188,202,231,257,284,330,336],"patient":[62],"(3).":[63,132],"Therefore,":[64,296],"EGFR-associated":[66],"TK":[67,77,93],"EGFR":[70],"have":[71,115],"been":[72,116,165],"respectively":[73,343],"targeted":[74],"inhibitors":[78,94],"or":[80,171,287,332,357],"monoclonal":[82],"antibodies":[83],"(MAbs)":[85],"treatment":[88,128,154],"cancers.":[90],"Although":[91],"MAbs":[96,345],"are":[97],"being":[98],"evaluated":[99,180,256],"clinical":[102],"trials":[103],",":[104,114],"only":[105],"two":[106],"MAbs,":[107],"cetuximab":[109],"panitumumab":[113],"approved":[117],"by":[118,139],"United":[120],"States":[121],"Food":[122],"Drug":[124],"Administration":[125],"malignant":[130,365],"Early":[133],"detection":[134],"cancer,":[137],"particularly":[138],"non-invasive":[140],"techniques":[141],"such":[142],"as":[143,185,248,288,297],"imaging,":[144,203],"could":[145,279],"be":[146,215,280],"helpful":[147],"development":[150,210],"appropriate":[153],"monitor":[157],"progress":[159],"patient.":[162],"Cetuximab":[163],"has":[164],"conjugated":[166,315],"nuclides":[169],"(4)":[170],"optical":[172],"dyes":[173],"(5),":[174],"MAb":[177,270,313],"conjugates":[178],"were":[179],"preclinical":[183],"setting":[184],"imaging":[186,197,233,260,285,304,331],"agents":[187,198],"cancerous":[189],"overexpress":[192],"EGFR.":[193],"However,":[194],"these":[195],"MAb-based":[196],"had":[199],"limited":[200,282],"application":[201],"investigators":[206],"concluded":[207],"further":[209],"bioagents":[213],"would":[214],"necessary":[216],"before":[217],"use":[218,338],"humans":[220,262],"(4,":[221],"5).In":[222],"effort":[224,300],"develop":[226],"anti-EGFR":[228],"antibody":[229],"suitable":[230],"therapy":[235],"cancer":[237],"patients,":[238],"humanized":[240],"MAb,":[241],"h-R3":[242],"(the":[243],"murine":[244],"form":[245],"ior":[249,310],"egf/r3),":[250],"was":[251,314,346],"labeled":[252,269,324,344],"99mTc":[254,327],"safety":[258],"(6-8).":[263],"A":[264],"high":[265],"accumulation":[266],"liver":[272],"patients":[275],"suggested":[276],"99mTc-h-R3":[278],"value":[283],"purposes":[286],"therapeutic":[290,306,337],"tool":[291],"clinics":[294],"(8).":[295],"preliminary":[299],"improve":[302],"properties":[307],"nuclide-labeled":[309],"egf/r3,":[311],"phenylalanine":[318],"derivative":[319],"1,4,7,10-tetraazacyclododecane-N,N\u2019,N\u2019\u2019,N\u2019\u2019\u2019-tetraacetic":[321],"acid":[322],"(DOTA-Ph-Al),":[323],"either":[326,352],"([99mTc]Ph-Al-ior":[328],"egf/r3)":[329,335],"90Y":[333],"([90Y]Ph-Al-ior":[334],"(9).":[339,370],"Biodistribution":[340],"studied":[347],"mice":[349,359],"grafted":[350],"Ehrlich":[353],"ascites":[354],"(EA)":[355],"bearing":[360],"U-87MG":[361],"(of":[363],"human":[364],"glioma":[366],"origin)":[367],"xenograft":[368]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-06-24T00:00:00"}